Lyme Disease

  • Danya Reich
  • Corinna Eleni Psomadakis
  • Bobby Buka


Lyme disease is an infectious disease caused by the Borrelia spirochetes, which are transmitted by Ixodes ticks, and it is endemic in the northeastern States of the USA. The disease most often causes a distinct rash known as erythema migrans, nonspecific flu-like symptoms, and arthralgia. Lyme disease is treated with a 14-day course of oral antibiotics (typically doxycycline). Untreated Lyme disease can lead to neurological and, rarely, cardiovascular complications. The majority of patients experience rash resolution within a few weeks and other symptom resolution within a few months of initiating treatment.


Erythema migrans Lyme Lyme disease Borreliosis Borrelia burgdorferi Borrelia Spirochete Reactive arthritis Ixodes Ticks Deer tick Ixodes scapularis Babesiosis Vector-borne Tick-borne Arthralgia Chronic Lyme disease Post-treatment Lyme disease syndrome Antibiotics Doxycycline Bell’s palsy Trigeminal neuralgia 


  1. 1.
    Oliveira CR, Shapiro ED. Update on persistent symptoms associated with Lyme disease. Curr Opin Pediatr. 2015;27(1):100–4.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089–134.CrossRefPubMedGoogle Scholar
  3. 3.
    Shapiro ED. Lyme disease. N Engl J Med. 2014;371(7):684.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015;57:82–115.CrossRefPubMedGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention. Reported cases of Lyme disease by state or locality, 2004–2013. [Online] 2015. Available from: Accessed 27 Mar 2015.
  6. 6.
    Feder Jr HM, Johnson BJ, O’Connell S, Shapiro ED, Steere AC, Wormser GP, Ad Hoc International Lyme Disease Group, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith Jr RP, Sood S, Weinstein A, Wong SJ, Zemel L. A critical appraisal of “chronic Lyme disease”. N Engl J Med. 2007;357(14):1422–30.CrossRefPubMedGoogle Scholar
  7. 7.
    Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med. 2003;348(24):2472–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Tiger JB, Guill III MA, Chapman MS. Bullous Lyme disease. J Am Acad Dermatol. 2014;71(4):e133–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Marques A. Chapter 16: Chronic Lyme Disease. In: Halperin JJ, editor. Lyme disease: an evidence-based approach. Wallingford, England: CABI Publishing; 2011.Google Scholar
  10. 10.
    Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345(2):85–92.CrossRefPubMedGoogle Scholar
  11. 11.
    Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, Dattwyler R, Chandler B. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60(12):1923–30.CrossRefPubMedGoogle Scholar
  12. 12.
    Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992–1003.CrossRefPubMedGoogle Scholar
  13. 13.
    Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001;345(2):79–84.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Open Access This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Danya Reich
    • 1
  • Corinna Eleni Psomadakis
    • 2
  • Bobby Buka
    • 3
  1. 1.Department of Family MedicineMount Sinai School of Medicine Attending Mount Sinai Doctors/Beth Israel Medical Group-WilliamsburgBrooklynUSA
  2. 2.School of Medicine Imperial College LondonLondonUK
  3. 3.Department of DermatologyMount Sinai School of MedicineNew YorkUSA

Personalised recommendations